Finweek English Edition - - FEEDBACK -

I would like to vent my very neg­a­tive feel­ings with re­gard to Litha Health­care’s ac­tions over the past few months.

This is an op­er­a­tion whose man­age­ment and prod­uct en­cour­aged in­vestors to be­lieve that the com­pany could well be a mini Aspen in the mak­ing.

A fur­ther en­cour­age­ment of its po­ten­tial growth was the fact that it en­tered into very long and on­go­ing talks with sup­posed BEE part­ners.

Th­ese talks were in fact log­i­cal as the sale of many of the com­pany’s prod­ucts would have been en­hanced if tied in with po­ten­tial State-driven busi­nesses via schools, hos­pi­tals, etc.

In the wake of the never-end­ing “cau­tion­ary no­tices” that never pro­vided much in­for­ma­tion to share­hold­ers, we are sud­denly ad­vised that it’s propos­ing to delist at a sug­gested price of R3.90. This far off the high of around R4.55/share.

My per­sonal opin­ion is that the com­pany must ad­vise why it’s propos­ing delist­ing. Or is it that in the wake of its BEE talks, there may well be very large fu­ture prof­its that it has no de­sire of shar­ing with pub­lic share­hold­ers?

Newspapers in English

Newspapers from South Africa

© PressReader. All rights reserved.